NFE2L2 and non-small cell lung carcinoma: The most common mechanisms promoting constitutive NRF2 activation are LOF mutations of KEAP1 and GOF mutations of NFE2L2 [74], which are frequently found in NSCLC sub-types [10,95] (see Section 3.2).